Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study

Archives of Ophthalmology

Volumn 123, Issue 9, 2005, Pages 1201-1206

  Keltner, John L ^a   Johnson, Chris A ^b   Levine, Richard A ^c   Fan, Juanjuan ^c   Cello, Kimberly E ^a   Kass, Michael A ^d   Gordon, Mae O ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEVERS EYE INSTITUTE   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; VISUAL FIELD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; INTRAOCULAR PRESSURE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PERIMETRY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VISUAL DISORDER;

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PERIMETRY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VISION DISORDERS; VISUAL FIELDS;

EID: 24944591118     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.9.1201     Document Type: Article

References (41)

1. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
2. Keltner JL, Johnson CA, Quigg JM, et al. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study: Ocular Hypertension Treatment Study Group. Arch Ophthalmol. 2000;118:1187-1194.
3. Keltner JL, Johnson CA, Cello KE, et al. Classification of visual field abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2003;121:643-650.
4. Draper NR, Smith H. Applied Regression Analysis. New York, NY: John Wiley & Sons; 1981:239.
5. Cook RD, Weisberg S. Applied Regression Including Computing and Graphics. New York, NY: John Wiley & Sons; 1999:318.
6. Pinheiro JC, Bates DM. Fitting Linear Mixed-Effects Models, Mixed-Effects Models in S and S-PLUS. New York, NY: Springer; 2000.
7. Holmin C, Krakau CE. Variability of glaucomatous visual field defects in computerized perimetry. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979;210:235-250.
8. Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108:130-135.
9. Chauhan BC, Tompkins JD, LeBlanc RP, et al. Characteristics of frequency-of-seeing curves in normal subjects, patients with suspected glaucoma, and patients with glaucoma. Invest Ophthalmol Vis Sci. 1993;34:3534-3540.
10. Wall M, Maw RJ, Stanek KE, et al. The psychometric function and reaction times of automated perimetry in normal and abnormal areas of the visual field in patients with glaucoma. Invest Ophthalmol Vis Sci. 1996;37:878-885.
11. Heijl A, Lindgren G, Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol. 1987;105:1544-1549.
12. Hart WM, Becker B. The onset and evolution of glaucomatous visual field defects. Ophthalmology. 1982;89:268-279.
13. Schulzer M. Errors in the diagnosis of visual field progression in normal-tension glaucoma. Ophthalmology. 1994;101:1589-1594.
14. Chauhan BC, House PH, McCormick TA, et al. Comparison of conventional and high pass resolution perimetry in a prospective study of patients with glaucoma and healthy controls. Arch Ophthalmol. 1999;117:24-33.
15. Werner EB, Petrig B, Krupin T, et al. Variability of automated visual fields in clinically stable glaucoma patients. Invest Ophthalmol Vis Sci. 1989;30:1083-1089.
16. Boeglin RJ, Caprioli J, Zulauf M. Long-term fluctuation of the visual field in glaucoma. Am J Ophthalmol. 1992;113:396-400.
17. Keltner JL, Johnson CA, Cello KE, et al. Visual field technician performance in the Ocular Hypertension Treatment Study (OHTS) [abstract]. Invest Ophthalmol Vis Sci. 2001;42:S152.
18. Leske MC, Heijl A, Hyman L, Bengtsson B. Early manifest glaucoma trial: design and baseline data. Ophthalmology. 1999;106:2144-2153.
19. AGIS Investigators. Advanced Glaucoma Intervention Study 2: visual field test scoring and reliability. Ophthalmology. 1994;101:1445-1455.
20. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 1: study design and methods and baseline characteristics of study patients. Control Clin Trials. 1994;15:299-325.
21. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 7: the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429-440.
22. Musch DC, Lichter PR, Guire KE, et al. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653-662.
23. Heijl A, Lindgren G, Olsson J, et al. Visual field interpretation with empiric probability maps. Arch Ophthalmol. 1989;107:204-208.
24. Schwartz B, Nagin P. Probability maps for evaluating automated visual fields. Doc Ophthalmol Proc Ser. 1985;42:39-48.
25. Katz J. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment. Ophthalmology. 1999;106:391-395.
26. Lee AC, Sample PA, Blumenthal EZ, et al. Comparison of visual field progression algorithms [abstract]. Invest Ophthalmol Vis Sci. 1999;40(suppl):S68.
27. Wild JM, Hutchings N, Hussey MK, et al. Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma. Ophthalmology. 1997;104:808-815.
28. Spry PG, Johnson CA. Identification of progressive glaucomatous visual field loss. Surv Ophthalmol. 2002;47:158-173.
29. Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 2003;44:3873-3879.
30. Holmin C, Krakau CE. Regression analysis of the central visual field in chronic glaucoma cases: a follow-up study using automatic perimetry. Acta Ophthalmol (Copenh). 1982;60:267-274.
31. Spry PG, Bates AB, Johnson CA, et al. Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci. 2000;41:2192-2200.
32. Birch MK, Wishart PK, O'Donnell NP. Determining progressive visual field loss in serial Humphrey visual fields. Ophthalmology. 1995;102:1227-1234.
33. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419-1428.
34. Mikelberg FS, Drance SM. The mode of progression of visual field defects in glaucoma. Am J Ophthalmol. 1984;98:443-445.
35. Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol. 1986;101:1-6.
36. Lee AC, Sample PA, Blumenthal EZ, et al. Infrequent confirmation of visual field progression. Ophthalmology. 2002;109:1059-1065.
37. Nouri-Mahdavi K, Brigatti L, Weitzman M, et al. Comparison of method to detect visual field progression in glaucoma. Ophthalmology. 1997;104:1228-1236.
38. Rasker MT, van den Enden A, Bakker D, et al. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol. 2000;118:481-488.
39. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131:699-708.
40. Kwon YH, Chang-Sik K, Zimmerman BM, et al. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol. 2001;132:47-56.
41. Chen PP. Correlation of visual field progression between eyes in patients with open-angle glaucoma. Ophthalmology. 2002;109:2093-2099.